Xspray Pharma AB's total assets for Q1 2026 were kr736.39M, a decrease of -4.28% from the previous quarter. SE:XSPRAY total liabilities were kr167.03M for the fiscal quarter, a 1.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.